HomeVYNE • NASDAQ
add
Vyne Therapeutics Inc
Previous close
$0.62
Day range
$0.60 - $0.63
Year range
$0.28 - $1.98
Market cap
21.15M USD
Avg Volume
293.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 130.00K | 54.76% |
Operating expense | 5.35M | -58.39% |
Net income | -4.84M | 59.77% |
Net profit margin | -3.72K | 74.00% |
Earnings per share | — | — |
EBITDA | -5.21M | 59.17% |
Effective tax rate | -0.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.01M | -52.84% |
Total assets | 30.16M | -54.92% |
Total liabilities | 2.40M | -83.84% |
Total equity | 27.76M | — |
Shares outstanding | 33.32M | — |
Price to book | 0.75 | — |
Return on assets | -39.36% | — |
Return on capital | -43.60% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.84M | 59.77% |
Cash from operations | -3.76M | 58.17% |
Cash from investing | 8.46M | -33.58% |
Cash from financing | -15.00K | 88.64% |
Net change in cash | 4.68M | 29.78% |
Free cash flow | -2.19M | 54.16% |
About
Founded
2003
Headquarters
Website
Employees
10
